Tirzepatide (LY3298176) is a synthetic 39-amino-acid peptide studied in preclinical models as a dual agonist of the GIP and GLP-1 receptors a mechanism researchers describe as twincretin pharmacology
For experimental autoimmune uveitis, abnormal activation of retinal microglia activated by YY1 lactylation also provides strong evidence that the subtype transitions of microglia are closely regulated by this PTM [38]
Central nervous system involvement is further supported by GLP-1 production in caudal brainstem neurons, key integrators of vagus nerve-mediated gut-brain signaling 53,54,55,56
Specifications Storage & Handling Lyophilized BPC-157 research material should be stored at -20C, kept away from humidity and UV exposure
As a once-weekly injectable medication, it works by enhancing insulin secretion in response to meals, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways
Does retatrutide cause more side effects than tirzepatide